EMIT 2000 Sirolimus Assay

Monitoring sirolimus levels in transplant patients is essential to ensuring the delicate balance between appropriate immunosuppression and transplant rejection. With the EMIT^® 2000 sirolimus method, laboratories have a flexible and convenient solution to help clinicians effectively manage sirolimus therapy in their transplant patients.

Features 

• Simple sample pretreatment
• Results in as little as 14 minutes
• No reagent preparation required
• Correlates to LC/MS/MS

Advantages

• Streamlined ISD monitoring and enhanced productivity
• Benefit from up to 4 different ISD methods on one single V-Twin^® or Viva-E^® drug testing system*